|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
540,054 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,092,104 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,587 |
|
|
Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 18 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-10-31 |
4 |
OE |
$9.86 |
$29,580 |
D/D |
3,000 |
178,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-24 |
4 |
AS |
$48.38 |
$290,252 |
D/D |
(6,000) |
178,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-06-03 |
4 |
S |
$59.88 |
$59,876 |
D/D |
(1,000) |
179,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-15 |
4 |
D |
$57.44 |
$283,294 |
D/D |
(4,932) |
180,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-12-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
630 |
180,261 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-10-12 |
4 |
OE |
$9.86 |
$29,580 |
D/D |
3,000 |
180,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-26 |
4 |
OE |
$12.99 |
$90,930 |
D/D |
7,000 |
180,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
540 |
181,501 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-09-14 |
4 |
OE |
$9.86 |
$39,440 |
D/D |
4,000 |
181,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-09-28 |
4 |
OE |
$9.86 |
$39,440 |
D/D |
4,000 |
181,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-11-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
160 |
182,041 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-14 |
4/A |
GD |
$0.00 |
$0 |
I/I |
600 |
182,201 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-14 |
4 |
OE |
$9.86 |
$147,900 |
D/D |
15,000 |
183,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-16 |
4 |
OE |
$9.86 |
$147,900 |
D/D |
15,000 |
183,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-27 |
4 |
OE |
$12.99 |
$51,960 |
D/D |
4,000 |
184,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-12 |
4 |
D |
$59.30 |
$270,823 |
D/D |
(4,567) |
185,189 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-08 |
4 |
D |
$56.78 |
$311,098 |
D/D |
(5,479) |
189,756 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-15 |
4 |
D |
$92.50 |
$1,451,325 |
D/D |
(15,690) |
190,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-16 |
4 |
AS |
$91.96 |
$459,800 |
D/D |
(5,000) |
190,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-11 |
4 |
OE |
$6.46 |
$212,500 |
D/D |
25,000 |
194,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
78,750 |
194,520 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-04-30 |
4 |
A |
$29.69 |
$21,228 |
D/D |
715 |
195,235 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-16 |
4 |
OE |
$71.33 |
$356,650 |
D/D |
5,000 |
195,674 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-03 |
4 |
D |
$93.95 |
$844,517 |
D/D |
(8,989) |
206,364 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-09 |
4 |
AS |
$90.18 |
$541,080 |
D/D |
(6,000) |
206,364 |
0 |
- |
|
853 Records found
|
|
Page 18 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|